Hormone replacement therapy may help prevent chronic wounds in elderly patients

February 22, 2002

(Philadelphia, PA) -- The question of whether post-menopausal women should subscribe to Hormone Replacement Therapy (HRT) is one of the most controversial issues in medicine today, as scientists debate the benefits and risks associated with taking estrogen over an extended period.

Now, research at the University of Pennsylvania School of Medicine has revealed another possible plus for HRT: Older patients taking estrogen may be significantly less likely to suffer from two of the most common and slow-to-heal wounds that afflict the elderly: pressure ulcers (often described as "bed sores") and venous leg ulcers.

The finding by David Margolis, MD, PhD, Associate Professor of Dermatology at Penn, is published this week in the journal The Lancet.

For the Study, Margolis reviewed the records of 44,195 female patients.

"Our research indicates that patients receiving HRT are around 35 percent less likely to develop a venous leg ulcer or pressure ulcer, which we view as early evidence that HRT may have a place in preventing chronic wounds," said Margolis, who holds a secondary appointment in Penn's Department of Biostatistics and Epidemiology.
-end-
The study was funded by the National Institute of Arthritis, Muscular, Skeletal and Skin Diseases, which is part of the National Institutes of Health.

Others who participated in the study are: Warren Bilker, PhD, Assistant Professor of Biostatistics and Epidemiology, and Jill Knauss, MA, in the Department of Biostatistics and Epidemiology.

University of Pennsylvania School of Medicine

Related Hormone Replacement Therapy Articles from Brightsurf:

Number of people in need of renal replacement therapy is rising
The 2017 Annual Report of the ERA-EDTA Registry [1] reveals that only a small fraction of patients accepted for renal replacement therapy are able to start this treatment with the best available therapy, which is transplantation, -- and that the number of people who are in need of renal replacement therapy is rising.

Ribociclib plus hormone therapy extends survival for patients with premenopausal advanced hormone receptor-positive breast cancer
Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in premenopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

Next step towards replacement therapy in type 1 diabetes
Scientists have discovered the signals that determine the fate of immature cells in the pancreas.

Testosterone replacement therapy may slow the progression of COPD
GALVESTON, Texas -- Researchers from The University of Texas Medical Branch at Galveston found that testosterone replacement therapy may slow disease progression of chronic obstructive pulmonary disease.

Improving cell replacement therapy for Parkinson's disease
Researchers describe a new set of cell surface markers on dopaminergic progenitor cells, which allow isolation of a more beneficial population of induced neurons for cell replacement therapy.

Novel hormone replacement therapy trial demonstrates improved memory function in adrenal patients
Timing cortisol replacement therapies to replicate secretion patterns in people with normal levels of the hormone has shown significant improvements in patients' cognitive function in a new trial led by University of Bristol scientists.

Hormone replacement therapy may protect against eye disease
Women who took estrogen-only hormone replacement therapy after ovary removal had a lower risk of developing glaucoma, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.

Hormone replacement therapy may be beneficial for women's memory
A new USC study indicates a potential benefit of the menopausal therapy for a certain type of memory.

Hormone replacement therapies help breast cancer grow and spread
Research has indicated that women who take hormone replacement therapies have a higher incidence of breast cancer.

Hormone replacement therapy associated with lower mortality
Women using hormone replacement therapy to relieve the symptoms of menopause faced a lower risk of death and showed lower levels of atherosclerosis, or plaque buildup in the heart's arteries, compared to women not using hormone therapy, according to a single-center study scheduled for presentation at the American College of Cardiology's 66th Annual Scientific Session.

Read More: Hormone Replacement Therapy News and Hormone Replacement Therapy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.